Finer Wealth Management Inc. Has $398,000 Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Finer Wealth Management Inc. trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.8% in the fourth quarter, Holdings Channel.com reports. The firm owned 763 shares of the medical equipment provider’s stock after selling 74 shares during the quarter. Finer Wealth Management Inc.’s holdings in Intuitive Surgical were worth $398,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of ISRG. Atala Financial Inc bought a new position in shares of Intuitive Surgical during the fourth quarter worth about $25,000. Berbice Capital Management LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $28,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Summit Securities Group LLC bought a new stake in shares of Intuitive Surgical in the fourth quarter worth $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have issued reports on ISRG. UBS Group lifted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Royal Bank of Canada lifted their target price on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. CICC Research started coverage on Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target for the company. Citigroup boosted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Finally, Evercore ISI increased their price objective on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Stock Down 0.4 %

Shares of NASDAQ:ISRG opened at $488.27 on Wednesday. The stock has a market cap of $173.91 billion, a PE ratio of 76.17, a P/E/G ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00. The business has a 50 day moving average of $528.70 and a 200-day moving average of $532.45.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the completion of the sale, the executive vice president now owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock worth $17,691,621 in the last ninety days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.